Current Issue

Atrial Fibrillation Certification Program at Genesis HealthCare System

Atrial fibrillation (a-fib) is the most common cardiac arrhythmia and has become recognized as a health concern that may lead to stroke and possible death. More than 2.5 million patients in the United States have a-fib, and the numbers are rapidly increasing as our population ages. A-fib patients use more healthcare services and have much higher healthcare costs than those without the disease.



Sneak Preview: The Heart Rhythm Society’s 33rd Annual Scientific Sessions

This spring, professionals from all over the world representing all facets of the heart rhythm community will meet in Boston for the Heart Rhythm Society’s 33rd Annual Scientific Sessions, May 9-12, 2012. More than 14,000 total attendees will explore the science, discovery, and innovation behind new research, technologies, therapies, and approaches to improve the care of patients with heart rhythm disorders.



Spotlight Interview: Merkezi Klinika Hospital

Merkezi Klinika (MK) Hospital is located in the center of Baku, the capital of the Azerbaijan Republic. MK Heart Center has pioneered the development of cardiovascular surgery, interventional cardiology and EP in their country, and now has extensive expertise in all areas of cardiovascular medicine. It is equipped with the latest technology and offers a full range of state-of-the-art diagnostic and therapeutic cardiovascular services.



A Comparison of the New Anticoagulants for Use in Atrial Fibrillation

Atrial fibrillation (AF) is the most common cardiac rhythm disorder, affecting at least 1% of the general population. After age 80 this increases to 10% of the population.1 In addition, the presence of AF is responsible for a 4- to 5-fold increase in the risk of ischemic stroke.2

Treatment for ischemic stroke prevention in the past has been limited to warfarin, a vitamin K antagonist, and aspirin.



MR Conditional ICD Technology: Update

Magnetic resonance imaging (MRI) is a diagnostic technique used to obtain high-quality images of the human body. In the last few years, MRI has become the imaging modality of choice across a broad range of indications. Compared with other techniques such as computer tomography (CT) or x-rays, MRI is characterized by having much better contrast between different soft tissues of the body. Furthermore, MRI has no associated health risks compared to x-ray or other ionizing radiation.



Early Experiences with Novel Quadripolar Technology

Presentation

The patient is an 81-year-old female with a non-ischemic cardiomyopathy and a left ventricular ejection fraction (LVEF) of 9%. She was admitted for CHF exacerbation and was previously treated with beta-blockers, ACE inhibitors, and a diuretic. The ECG showed sinus rhythm with LBBB and a QRS duration of 130 msec.



10-Minute Interview: Jagmeet P. Singh, MD, DPhil

This month we speak with Jagmeet P. Singh, MD, DPhil, Associate Professor of Medicine, Harvard Medical School, Cardiac Arrhythmia Service, Massachusetts General Hospital Heart Center.

Tell us about your medical background and how you came to work in the field of electrophysiology. What interested you about this field?

My journey so far has zigzagged across 3 continents. I started out in India, where I received my basic medical education and initial training in medicine and cardiology.



Case Study: Pacemaker Twiddler’s Syndrome

Case Description

An elderly 91-year-old female patient was admitted for paroxysmal atrial fibrillation in September 2011. During this admission, she was evaluated for and received a permanent pacemaker. Later that night, the patient became very agitated and dislodged her atrial lead. The patient was taken back to the cardiac cath lab for a lead revision the following morning.



Cryoballoon Ablation at the Mayo Clinic

Atrial fibrillation is the most commonly encountered arrhythmia in clinical medicine. The presence of atrial fibrillation is associated with an increased risk of stroke, and patients may complain of palpitations, shortness of breath, and fatigue. Buoyed by the success of ablation for paroxysmal supraventricular arrhythmias and atrial flutter, over the last 15 years investigators from around the world have focused on developing catheter-based ablation techniques for the treatment of atrial fibrillation.



The Riata Recall

On December 14, 2011, the Food and Drug Administration (FDA) classified St. Jude Medical’s Riata defibrillator lead recall as a Class I recall, because of the “potential risk of serious injury or patient death if affected devices malfunction.”1



  • « Previous
  •  | Page 1 of 2 | 
  • Next »